Tourmaline Bio
在场
高管
查看带有其 18 名主要高管的组织结构图
Tourmaline Bio 搜索最多的简介
- Sandeep Kulkarni, Chief Executive Officer and Director
- Aaron Kantoff, Director
- Clay Siegall, Chairman of the Board
高管在Tourmaline Bio变化
- Yung Chyung, Chief Medical Officer, 已经离开公司 (新闻发布的2024十二月5号).
- Ryan Robinson 曾任 Interim Chief Financial Officer, 现升职为 Chief Financial Officer (新闻发布的2024六月27号).
创建提醒
跟踪 Tourmaline Bio 的高管变动
生物技术
Tourmaline Bio 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Tourmaline Bio 的最新新闻稿
- Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day | Tourmaline Bio, Inc.
- News | Tourmaline Bio, Inc.
- Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024 | Tourmaline Bio, Inc.
- Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Tourmaline Bio, Inc.
- Tourmaline Bio to Present at Upcoming Investor Conferences | Tourmaline Bio, Inc.
- Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress | Tourmaline Bio, Inc.
- Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024 | Tourmaline Bio, Inc.
- Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board | Tourmaline Bio, Inc.
- Tourmaline Bio to Present at Upcoming Investor Conferences | Tourmaline Bio, Inc.
- Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights | Tourmaline Bio, Inc.
- View more press releases Close
关于 Tourmaline Bio 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Clay Siegall 
